Business
Izotropic’s IzoView Breast CT the First in Category to Offer Patent-Pending Personalized Radiation Dose
- Patent-pending pre-scan technology enables custom radiation dose tailored to patient’s unique breast size and composition - - Feature aligns with personalized medicine trends driving the global breast imaging device market size to USD $8.69 billion by 2030 - - Integrated into the IzoView commercial model alongside modular engineering, compression-free imaging, and AI-driven image optimization - VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- via IBN – Iz
About this update from Izotropic Corp.
[{"type":"image","alt":"Izotropic","displaySize":"","headline":null,"caption":"Izotropic","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":83,"url":"https://media.zenfs.com/en/globenewswire.com/342f0108283f64b41bf05ed2af94ca63"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/BChRXr4MzGGT2dgplDeEaQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExNjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/342f0108283f64b41bf05ed2af94ca63","width":300,"height":83}},"lazy":false},{"type":"text","content":"- Patent-pending pre-scan technology enables custom radiation dose tailored to patient’s unique breast size and composition -","length":125,"tagName":"p"},{"type":"text","content":"- Feature aligns with personalized medicine trends driving the global breast imaging device market size to USD $8.69 billion by 2030 -","length":134,"tagName":"p"},{"type":"text","content":"- Integrated into the IzoView commercial model alongside modular engineering, compression-free imaging, and AI-driven image optimization -","length":138,"tagName":"p"},{"type":"text","content":"VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the integration of a new patent-pending radiation dose personalization feature into its flagship device, the IzoView Breast CT Imaging System. This proprietary capability positions IzoView as the first breast CT system to offer real-time customized radiation dosing, using an integrated radiation-free optical pre-scan feature and proprietary software.","length":746,"tagName":"p"},{"type":"text","content":" Radiation Dose Personalization Engineered into IzoView Using Optical Pre-Scan","length":77,"tagName":"p"},{"type":"text","content":"The optical pre-scan system captures a radiation-free image of the breast and uses it to calculate a personalized radiation dose, custom to each patient’s breast size. The system uses this pre-scan data and dose reference models developed at UC Davis Medical Center (“UC Davis”), where breast CT technology was founded and advanced through over two decades ...